Latest News

Friday, April 21, 2017 | Clinical Trials

Powered by CIRM Grant, jCyte Launches New Clinical Trial

Cell therapy company jCyte is launching a phase 2b clinical trial to test the safety and efficacy of its developmental retinitis pigmentosa (RP) treatment, jCell. The company is recruiting 70 pa…

Read the full story

Friday, April 21, 2017 | Partnerships,Retina, ThromboGenics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics

Bicycle Therapeutics announced the receipt of a preclinical milestone in connection with the advancement of a Bicycle into preclinical development for the treatment of diabetic macular edema, under it…

Read the full story

Friday, April 21, 2017 | Acquisitions/Mergers, Beaver-Visitec International, BVI

Beaver-Visitec International to Acquire Malosa Medical

Beaver-Visitec International announced that it has acquired Malosa Medical, a manufacturer and supplier of single-use surgical instruments primarily for use in the field of ophthalmology.  Ter…

Read the full story

Friday, April 21, 2017 | Health Care

Alphabet's Verily Unit Launches Study to Track Health Data

Verily, Alphabet Inc's life sciences business, said it was launching a four-year study with about 10,000 participants to understand how people transition from being healthy to becoming sick, and t…

Read the full story

Thursday, April 20, 2017 | Optometry

The Eye Center Offers the InfantSEE Eye Program for Infants

Vision issues in infants can interfere with the achievement of developmental milestones. The InfantSEE eye program, supported through the Jimmy Carter Fund, allows infants between 6 to 12 months of ag…

Read the full story

Thursday, April 20, 2017 | Medical Studies,Retina

Okayama University Research: Successful Test of Retinal Prosthesis Implanted in Rats

Researchers at Okayama University report in the Journal of Artificial Organs the promising performance of a retinal prosthesis material when implanted in rats. The material is capable of converting ex…

Read the full story

Thursday, April 20, 2017 | Medical Studies,Retina

IBM Machine Vision Technology Advances Early Detection of Diabetic Eye Disease Using Deep Learning

IBM this week released the results of new research using deep learning and visual analytics technology to advance early detection of diabetic retinopathy (DR). The results, which classify the degree o…

Read the full story

Thursday, April 20, 2017 | Clinical Trials, Clearside Biomedical

Clearside Biomedical Announces Completion of Patient Enrollment in Phase 1/2 Clinical Trial of CLS-TA in Diabetic Macular Edema

Clearside Biomedical announced completion of enrollment of an exploratory clinical trial (HULK trial) of CLS-TA for suprachoroidal administration, its proprietary suspension formulation of the cortico…

Read the full story

Thursday, April 20, 2017 | Clinical Trials

Eyevensys Receives Approval from the UK Medicines and Healthcare Products Regulatory Agency to Advance its EyeCET Platform Into Clinical Development

Eyevensys announced it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to advance its technology into clinical development. Eyevensys is developing its pro…

Read the full story

Thursday, April 20, 2017 | Medical Studies

Targeted Retinopathy Screening Proposed in Type 1 Diabetes

A data-based model for individualizing retinopathy screening schedules for patients with type 1 diabetes could significantly reduce the frequency of eye exams without delaying the diagnosis of sight-t…

Read the full story

Wednesday, April 19, 2017 | Cataract Surgery,Partnerships, Carl Zeiss Meditec

First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical Center San Diego

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, MD, Program Director, Navy Refractive Surgery Center San Diego. These procedures for the US Navy fol…

Read the full story

Wednesday, April 19, 2017 | Corporate Lawsuits, Allergan

Allergan, Argentum Settle Patent Dispute Over Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, …

Read the full story

Wednesday, April 19, 2017 | Partnerships

H.I.G. Capital Makes a Strategic Investment in Barnet Dulaney Perkins and Southwestern Eye Center

H.I.G. Capital, a global private equity investment firm with $21 billion of equity capital under management, announced that one of its affiliates has made a strategic investment in Barnet Dulaney Perk…

Read the full story

Wednesday, April 19, 2017 | Medical Studies

Flying Eyes Optics Sponsors Website Dedicated to Pilot-Friendly Opticians

Flying Eyes Optics sponsors EyesThatFly.com, a website dedicated to pilots, looking for eye care professionals who understand a pilot's unique vision requirements. The site www.EyesThatFly.com is …

Read the full story

Wednesday, April 19, 2017 | Medical Studies

‘Poppers’ Use Tied to Maculopathy

Using “poppers,” which are volatile alkyl nitrite compounds inhaled for their sexual enhancement and psychoactive effects, can be associated with maculopathy, according to a new case serie…

Read the full story
Load More